Simon Tual-Chalot
@SimonTualChalot
Principal Investigator / Endothelial cells / Ageing / Amyloid-beta / RNA modifications
ID:1724964331
https://www.ncl.ac.uk/medical-sciences/people/profile/simontual-chalot.html 03-09-2013 09:22:38
42 Tweets
150 Followers
370 Following
CLINICAL COMMENTARIES: First-in-human #gene editing for lipid lowering: the initial results
Simon Tual-Chalot & Konstantinos Stellos, MD explore interim data from the Heart-1 trial & what this means for the future of lipid-lowering therapy
academic.oup.com/cardiovascres/…
#CVD #CardiovascularResearch
Happy to share our position paper from the ESH WG on Small Arteries. If you want to learn more about vascular inflammation, this is the right paper for you🔥❤️👇ahajournals.org/doi/10.1161/HY… A special thank to F. Rios and A. Virdis! Hypertension CTEC - Zurich University Heart Center Università di Pisa
Interested in entering the RNA modifications wonderland in cardiometabolic diseases ? Join my lab Uni Heidelberg by applying for postdoc fellowship at Health + Life Science Alliance Heidelberg Mannheim 👇! Collaborative high-risk, high-rewarding projects with Johannes Backs and Felix J. Hartmann are waiting for you
Interesting data showing IP-10 levels are predictive of outcome following MI. Lead by Kateryna Sopova and Simon Tual-Chalot, seniors Ioakim Spyridopoulos Konstantinos Stellos, MD frontiersin.org/articles/10.33… @NUBiosciences Newcastle University
Really grateful to receive a British Heart Foundation project grant for my research.
Thanks to my mentor Konstantinos Stellos, MD, collaborators Richardsonlab Ioakim Spyridopoulos Jason Gill, Newcastle University support @NUBiosciences NCL_VascBiolMed and British Heart Foundation.
Excited to embark on this new chapter as a PI!
Interested in learning how RNA-binding proteins are involved in atherosclerosis? Read below our publication in Atherosclerosis co-authored with Marco Sachse and the Konstantinos Stellos, MD lab from @NUBiosciences and Uni Heidelberg
Are you interested in identifying new therapies for cardiovascular disease? We are recruiting a postdoc for a 2-year BHF-funded project. jobs.ncl.ac.uk/job/Newcastle-…
British Heart Foundation @NUBiosciences Newcastle University British Society for Cardiovascular Research NCL_VascBiolMed
Finally out in @jaccjournals: circulating cathepsin S is a predictor of long-term mortality and improves risk stratification of patients with NSTE-ACS. A novel residual risk biomarker or a therapeutic target? Read more here: jacc.org/doi/10.1016/j.… DZHK Germany
Check out our new review out now in Ageing Research Reviews, the result of roundtable discussions started at
COST17129 in Maastricht 2020. Congratulations to all authors. Amela Jusic Stephanie Bezzina Wettinger Emma Louise Robinson, PhD, FHFA
Konstantinos Stellos, MD sciencedirect.com/science/articl…
Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction academic.oup.com/eurheartj/adva…
European Society of Cardiology #EHJ #ESCYoung #cardiotwitter EHJ Editor-in-Chief R Ladeiras Lopes
An exciting British Heart Foundation funded post-doc research position is now available Newcastle University using single cell RNA-seq to unravel the genetics that control arch artery morphogenesis. See jobs.ncl.ac.uk/job/Newcastle-…. #cardiovascular #development . Contact me with any questions! #Retweet !
Our data is out in early view Aging Cell. 'Clearance of senescent cells during cardiac ischemia-reperfusion injury improves recovery'. Collaborative Science: Newcastle University School of Biological Sciences Mayo Clinic onlinelibrary.wiley.com/doi/10.1111/ac…. Passos Lab David Grieve Michael Taggart NCL_VascBiolMed